The Danish Medicines Agency has launched a new coordinated process that allows sponsors to apply for the simultaneous approval of so-called combined studies that involve a clinical trial of a medicinal product in parallel with the performance study of an in vitro diagnostic (IVD).
The DMA’s new process aims to address the ongoing issues facing sponsors of combined studies, who must seek regulatory...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?